Federal Register / Vol. 86, No. 168 / Thursday, September 2, 2021 / Notices 49343 

Meeting Purpose/Objective: The NIAC 

will meet in an open meeting on 

Wednesday, September 22, 2021, to 

present, deliberate, and vote on the 

Workforce and Talent Management 

Study Report. 

Public Participation 

Meeting Registration Information 

Requests to attend via conference call 

will be accepted and processed in the 

order in which they are received. 

Individuals may register to attend the 

NIAC meeting by phone by sending an 

email to NIAC@cisa.dhs.gov. 

Public Comment 

While this meeting is open to the 

public, participation in FACA 

deliberations are limited to council 

members. A public comment period will 

be held during the meeting from 

approximately 2:35 p.m.–2:45 p.m. EDT. 

Speakers who wish to comment must 

register in advance and can do so by 

emailing NIAC@cisa.dhs.gov no later 

than 5:00 p.m. EDT on Sunday, 

September 19, 2021. Speakers are 

requested to limit their comments to 

three minutes. Please note that the 

public comment period may end before 

the time indicated, following the last 

call for comments. 

Information on Services for Individuals 

With Disabilities 

For information on facilities or 

services for individuals with disabilities 

or to request special assistance at the 

meeting, please contact NIAC@

cisa.dhs.gov by 5:00 p.m. EDT on 

Sunday, September 19, 2021. 

Rachel Liang, 

Designated Federal Officer, President’s 

National Infrastructure Advisory Council, 

Cybersecurity and Infrastructure Security 

Agency, Department of Homeland Security. 

[FR Doc. 2021–18973 Filed 9–1–21; 8:45 am] 

BILLING CODE 9110–9P–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1279] 

Certain Flocked Swabs, Products 

Containing Flocked Swabs, and 

Methods of Using Same; Notice of 

Institution of Investigation 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that a 

complaint was filed with the U.S. 

International Trade Commission on July 

9, 2021, under section 337 of the Tariff 

Act of 1930, as amended, on behalf of 

Copan Italia S.p.A. of Brescia, Italy and 

Copan Industries, Inc. of Aguadilla, 

Puerto Rico. Supplements to the 

Complaint were filed on August 16, 

2021, August 19, 2021, and August 20, 

2021. The complaint, as supplemented, 

alleges violations of section 337 based 

upon the importation into the United 

States, the sale for importation, and the 

sale within the United States after 

importation of certain flocked swabs, 

products containing flocked swabs, and 

methods of using same by reason of 

infringement of certain claims of U.S. 

Patent No. 9,011,358 (‘‘the ’358 Patent’’); 

U.S. Patent No. 9,173,779 (‘‘the ’779 

Patent’’); and U.S. Patent No. 10,327,741 

(‘‘the ’741 Patent’’). The complaint 

further alleges that an industry in the 

United States exists as required by the 

applicable Federal Statute. The 

complainants request that the 

Commission institute an investigation 

and, after the investigation, issue a 

general exclusion order, or in the 

alternative a limited exclusion order, 

and cease and desist orders. 

ADDRESSES: The complaint, except for 

any confidential information contained 

therein, may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. For help 

accessing EDIS, please email 

EDIS3Help@usitc.gov. Hearing impaired 

individuals are advised that information 

on this matter can be obtained by 

contacting the Commission’s TDD 

terminal on (202) 205–1810. Persons 

with mobility impairments who will 

need special assistance in gaining access 

to the Commission should contact the 

Office of the Secretary at (202) 205– 

2000. General information concerning 

the Commission may also be obtained 

by accessing its internet server at 

https://www.usitc.gov. 

FOR FURTHER INFORMATION CONTACT: 

Pathenia M. Proctor, The Office of 

Unfair Import Investigations, U.S. 

International Trade Commission, 

telephone (202) 205–2560. 

SUPPLEMENTARY INFORMATION: 

Authority: The authority for 

institution of this investigation is 

contained in section 337 of the Tariff 

Act of 1930, as amended, 19 U.S.C. 

1337, and in section 210.10 of the 

Commission’s Rules of Practice and 

Procedure, 19 CFR 210.10 (2020). 

Scope of Investigation: Having 

considered the complaint, the U.S. 

International Trade Commission, on 

August 27, 2021, ordered that— 

(1) Pursuant to subsection (b) of 

section 337 of the Tariff Act of 1930, as 

amended, an investigation be instituted 

to determine whether there is a 

violation of subsection (a)(1)(B) of 

section 337 in the importation into the 

United States, the sale for importation, 

or the sale within the United States after 

importation of certain products 

identified in paragraph (2) by reason of 

infringement of one or more of claims 1, 

6–9, 11–14, 16–19, and 21–22 of the 

’358 patent; claims 1, 4–6, 8, 9, 11–13, 

16–20, and 22–24 of the ’779 patent; and 

claims 1, 3, 5, 7–10, 18, and 20 of the 

’741 patent; and whether an industry in 

the United States exists as required by 

subsection (a)(2) of section 337; 

(2) Pursuant to section 210.10(b)(1) of 

the Commission’s Rules of Practice and 

Procedure, 19 CFR 210.10(b)(1), the 

plain language description of the 

accused products or category of accused 

products, which defines the scope of the 

investigation, is ‘‘flocked swabs, such as 

nasopharyngeal swabs, and kits 

containing flocked swabs, that are used 

in the collection, sampling, or testing of 

and for infectious diseases such as 

influenza, SARS–CoV–2 (the 

coronavirus that causes COVID–19), and 

other diseases’’; 

(3) Pursuant to Commission Rule 

210.50(b)(1), 19 CFR 210.50(b)(1), the 

presiding administrative law judge shall 

take evidence or other information and 

hear arguments from the parties and 

other interested persons with respect to 

the public interest in this investigation, 

as appropriate, and provide the 

Commission with findings of fact and a 

recommended determination on this 

issue, which shall be limited to the 

statutory public interest factors set forth 

in 19 U.S.C. 1337(d)(1), (f)(1), (g)(1); 

(4) For the purpose of the 

investigation so instituted, the following 

are hereby named as parties upon which 

this notice of investigation shall be 

served: 

(a) The complainants are: 

Copan Italia S.p.A., Via F. Perotti 10, 

25125, Brescia, Italy 

Copan Industries, Inc., 1068 Ave. 

General Ramey, #789 San Antonio, 

Puerto Rico 00690 

(b) The respondents are the following 

entities alleged to be in violation of 

section 337, and are the parties upon 

which the complaint is to be served: 

Han Chang Medic, 79–35 Jangsan 2-Gil, 

Susin-Myeon, Dongnam-Gu, Cheonan, 

Chungnam, 31252, Republic of Korea 

Wuxi NEST Biotechnology Co., Ltd., No. 

530, Xida Road, Meicun Industrial 

Park, Xinwu District, Wuxi, Jiangsu, 

214112, China 

NEST Scientific Inc., 1592 Hart St Unit 

12, Rahway, NJ 07065–5519 

NEST Scientific USA, 1592 Hart St Unit 

12, Rahway, NJ 07065–5519 

Miraclean Technology Co., Ltd., 301, 

Bldg. A, No. 18 Factory Building, 


lotter on DSK11XQN23PROD with NOTICES1
49344 Federal Register / Vol. 86, No. 168 / Thursday, September 2, 2021 / Notices 

Rongshuxa Industrial Zone, Tongxin 

Community, Baolong Str., Longgang 

Dist., Shenzhen, Guangdong, 518116, 

China 

Vectornate Korea Ltd., 56 Nanosandan 

2-ro, Jinwon-myeon, Jangseong, 

Jeonnam, 57247, Republic of Korea 

Vectornate USA, Inc., 10 Industrial Ave 

Ste 4, Mahwah, NJ 07430–2284 

Innovative Product Brands, Inc., 7045 

Palm Avenue, Highland, CA 92346– 

3291 

Thomas Scientific, Inc., 1654 High Hill 

Rd, Swedesboro, NJ 08085–1780 

Thomas Scientific, LLC, 1654 High Hill 

Rd, Swedesboro, NJ 08085–1780 

Stellar Scientific, LLC, 40 New Plant Ct, 

Owings Mills, MD 21117–4356 

Cardinal Health, Inc., 7000 Cardinal Pl, 

Dublin, OH 43017–1091 

Ksl Biomedical, Inc., 1000 Youngs Rd 

Ste 210, Williamsville, NY 14221– 

2644 

Ksl Diagnostics, Inc., 1000 Youngs Rd 

Ste 207, Williamsville, NY 14221– 

2644 

Jiangsu Changfeng Medical Industry Co., 

Ltd., Seat of Touqiao Town, 

Guangling District, Yangzhou, 

Jiangsu, 225108, China 

No Borders Dental Resources, Inc., dba 

MediDent Supplies, 18716 E Old Beau 

Trl, Queen Creek, AZ 85142–3522 

BioTeke Corporation (Wuxi) Co., Ltd., 

4th Floor-A, D5, No. 1719, Huishan 

Avenue, Wuxi, Jiangsu, 214174, China 

Fosun Pharma USA Inc., 104 Carnegie 

Ctr Ste 204, Princeton, NJ 08540–6232 

Hunan Runmei Gene Technology Co., 

Ltd., Room 401, Building No. 3 in 

ChangSha Medical and Health 

Industrial Park, No. 1048 Zhong Qing 

Road, Kai Fu District, Changsha, 

Hunan, 410153, China 

VWR International, LLC, 100 W 

Matsonford Rd Ste 1, Radnor, PA 

19087–4565 

Slmp, LLC dba StatLab Medical 

Products, 2090 Commerce Dr., 

McKinney, TX 75069–8203 

(c) The Office of Unfair Import 

Investigations, U.S. International Trade 

Commission, 500 E Street SW, Suite 

401, Washington, DC 20436; and 

(5) For the investigation so instituted, 

the Chief Administrative Law Judge, 

U.S. International Trade Commission, 

shall designate the presiding 

Administrative Law Judge. 

Responses to the complaint and the 

notice of investigation must be 

submitted by the named respondents in 

accordance with section 210.13 of the 

Commission’s Rules of Practice and 

Procedure, 19 CFR 210.13. Pursuant to 

19 CFR 201.16(e) and 210.13(a), as 

amended in 85 FR 15798 (March 19, 

2020), such responses will be 

considered by the Commission if 

received not later than 20 days after the 

date of service by the complainants of 

the complaint and the notice of 

investigation. Extensions of time for 

submitting responses to the complaint 

and the notice of investigation will not 

be granted unless good cause therefor is 

shown. 

Failure of a respondent to file a timely 

response to each allegation in the 

complaint and in this notice may be 

deemed to constitute a waiver of the 

right to appear and contest the 

allegations of the complaint and this 

notice, and to authorize the 

administrative law judge and the 

Commission, without further notice to 

the respondent, to find the facts to be as 

alleged in the complaint and this notice 

and to enter an initial determination 

and a final determination containing 

such findings, and may result in the 

issuance of an exclusion order or a cease 

and desist order or both directed against 

the respondent. 

By order of the Commission. 

Issued: August 27, 2021. 

Katherine Hiner, 

Supervisory Attorney. 

[FR Doc. 2021–18932 Filed 9–1–21; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1278] 

Certain Radio Frequency Transmission 

Devices and Components Thereof 

Notice of Institution of Investigation 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that a 

complaint was filed with the U.S. 

International Trade Commission on July 

28, 2021, under section 337 of the Tariff 

Act of 1930, as amended, on behalf of 

Zebra Technologies Corporation of 

Lincolnshire, Illinois. A supplement to 

the complaint was filed on August 13, 

2021. The complaint, as supplemented, 

alleges violations of section 337 based 

upon the importation into the United 

States, the sale for importation, and the 

sale within the United States after 

importation of certain radio frequency 

transmission devices and components 

thereof by reason of infringement of 

certain claims of U.S. Patent No. 

6,895,219 (‘‘the ’219 patent’’) and U.S. 

Patent No. 7,683,788 (‘‘the ’788 patent’’). 

The complaint further alleges that an 

industry in the United States exists or 

is in the process of being established as 

required by the applicable Federal 

Statute. The complainant requests that 

the Commission institute an 

investigation and, after the 

investigation, issue a limited exclusion 

order and a cease and desist order. 

ADDRESSES: The complaint, as 

supplemented, except for any 

confidential information contained 

therein, may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. For help 

accessing EDIS, please email 

EDIS3Help@usitc.gov. Hearing impaired 

individuals are advised that information 

on this matter can be obtained by 

contacting the Commission’s TDD 

terminal on (202) 205–1810. Persons 

with mobility impairments who will 

need special assistance in gaining access 

to the Commission should contact the 

Office of the Secretary at (202) 205– 

2000. General information concerning 

the Commission may also be obtained 

by accessing its internet server at 

https://www.usitc.gov. 

FOR FURTHER INFORMATION CONTACT: 

Katherine Hiner, Office of Docket 

Services, U.S. International Trade 

Commission, telephone (202) 205–1802. 

SUPPLEMENTARY INFORMATION: 

Authority: The authority for 

institution of this investigation is 

contained in section 337 of the Tariff 

Act of 1930, as amended, 19 U.S.C. 

1337, and in section 210.10 of the 

Commission’s Rules of Practice and 

Procedure, 19 CFR 210.10 (2021). 

Scope of Investigation: Having 

considered the complaint, the U.S. 

International Trade Commission, on 

August 26, 2021, Ordered that— 

(1) Pursuant to subsection (b) of 

section 337 of the Tariff Act of 1930, as 

amended, an investigation be instituted 

to determine whether there is a 

violation of subsection (a)(1)(B) of 

section 337 in the importation into the 

United States, the sale for importation, 

or the sale within the United States after 

importation of certain products 

identified in paragraph (2) by reason of 

infringement of one or more of claims 1, 

3–8, and 10, 11, and 13–16 of the ’219 

patent and claims 17–19 of the ’788 

patent, and whether an industry in the 

United States exists or is in the process 

of being established as required by 

subsection (a)(2) of section 337; 

(2) Pursuant to section 210.10(b)(1) of 

the Commission’s Rules of Practice and 

Procedure, 19 CFR 210.10(b)(1), the 

plain language description of the 

accused products or category of accused 

products, which defines the scope of the 

investigation, is (i) ‘‘RF transmission 

devices generally capable of 

transmitting and receiving data; and (ii) 


lotter on DSK11XQN23PROD with NOTICES1